申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2004048335A2
                            
                            
                                公开(公告)日:2004-06-10
                            
                            The invention is concerned with novel mandelic acid derivatives of formula (I), wherein R1 to R10, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor and can be used as medicaments.